Bayer and Zantac Face Legal Challenges as Lawsuits Move Forward
===============	
#712533f1 ver:0.08

Bayer faces legal challenges as it seeks protection from Roundup cancer lawsuits. The company is lobbying for bills in Iowa, Missouri, and Idaho to shield pesticide companies from cancer risk claims. Critics worry about broader consequences. Bayer has already paid $10 billion in settlements and trials. Despite this, CEO Bill Anderson rules out a break-up but considers it in the future. Bayer aims for €2 billion in annual savings by 2026 and expects €47-49 billion in sales by 2024. In a separate development, a judge allows over 70,000 Zantac cancer lawsuits to proceed, despite objections from GSK, Pfizer, and Sanofi. #Bayer #Roundup #lawsuits #Zantac #cancer...

#newstr #Bayer #Roundup #Zantac #Lawsuits #Cancer #Gsk #Pfizer #Sanofi #Ndma #Fda 

 https://here.news/story/712533f1?ver=0.08